Clinical trials
Anemia, Hemolytic, Autoimmune trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bioverativ, a Sanofi company | 4 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Incyte Corporation | 1 |
| Kezar Life Sciences, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| RECORDATI GROUP | 1 |
| Sanofi | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Hemolytic, Autoimmune | 14 |
| Purpura, Thrombocytopenic, Idiopathic | 4 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Hematologic Diseases | 1 |
| Hemolysis | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Myelodysplastic Syndromes | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.